Average Co-Inventor Count = 3.09
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (39 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (2 from 363 patents)
3. J & J Pharmaceutical Research & Development, Llc. (1 from 1 patent)
42 patents:
1. 10618893 - GPR120 agonists for the treatment of type II diabetes
2. 10590083 - Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists
3. 10399944 - Pyridin-2-one derivatives of formula (III) useful as EP3 receptor antagonists
4. 10336701 - Pyridin-2-one derivatives of formula (II) useful as EP3 receptor antagonists
5. 10118922 - GPR120 agonists for the treatment of type II diabetes
6. 10077241 - Tetrahydro-benzoimidazolyl modulators of TGR5
7. 9771375 - Indazole compounds useful as ketohexokinase inhibitors
8. 9434688 - Indole derivatives as selective androgen receptor modulators (SARMS)
9. 9303037 - Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
10. 9067898 - Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes
11. 8921559 - 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2
12. 8822447 - Indazole compounds useful as ketohexokinase inhibitors
13. 8765782 - Indole derivatives as selective androgen receptor modulators (SARMS)
14. 8580840 - Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
15. 8513229 - 4-Azetidinyl-1-phenyl-cyclohexane antagonists of CCR2